BACKGROUND: Atrial fibrillation (AF) accounts for approximately one-third of hospitalizations for cardiac rhythm disturbances. Little is known about the characteristics of current use of cardioversion (CV) and its success rates in clinical practice in Germany. METHODS: As part of the international RHYTHM-AF Study, 655 consecutive patients with documented AF (mean age 68.3 ± 10.5 years, 64.9 % males) who were considered candidates for CV were prospectively enrolled in 22 German hospitals (21 academic/teaching and 1 non-teaching). CV was considered successful if sinus rhythm or atrial rhythm was obtained within 1 day after start of pharmacological CV (PCV) or if sinus rhythm was achieved and maintained for at least 10 min after electrical CV (ECV). RESULTS: Patients with AF considered for CV had ECG in 94.4 %, Holter ECG in 25.8 %, and transesophageal echocardiography (TEE) in 73.1 % of cases. They underwent ECV (after mean 16 h, range 4-48), in 65.3 % and PCV in 6.7 % of patients (amiodarone in 47.7 %, flecainide in 27.3 %, propafenone in 2.3 %) as first CV procedure. No CV was performed in 27.9 %, mainly due to spontaneous CV or pathologic TEE. Primary success rates were 86.7 % for electrical CV and 54.5 % for pharmacological CV. More patients in the ECV group compared to the PCV group received oral anticoagulation at discharge (79.2 vs. 59.1 %, p < 0.001), and at 60 days (77.5 vs. 56.8 %, p < 0.001). Further, at 60 days the proportion of patients in sinus rhythm was not different between groups (ECV 76.8 % vs. PCV 77.3 %). CONCLUSIONS: In large academic centres in Germany, the preferred CV method is electrical, mainly due to its easy access and to its higher success rate for the initial restoration of sinus rhythm. Considering the limitations of the open-label, non-randomised study design, overall short-term success rates appeared higher after ECV compared to PCV during hospitalisation, but not after 60 days.
BACKGROUND:Atrial fibrillation (AF) accounts for approximately one-third of hospitalizations for cardiac rhythm disturbances. Little is known about the characteristics of current use of cardioversion (CV) and its success rates in clinical practice in Germany. METHODS: As part of the international RHYTHM-AF Study, 655 consecutive patients with documented AF (mean age 68.3 ± 10.5 years, 64.9 % males) who were considered candidates for CV were prospectively enrolled in 22 German hospitals (21 academic/teaching and 1 non-teaching). CV was considered successful if sinus rhythm or atrial rhythm was obtained within 1 day after start of pharmacological CV (PCV) or if sinus rhythm was achieved and maintained for at least 10 min after electrical CV (ECV). RESULTS:Patients with AF considered for CV had ECG in 94.4 %, Holter ECG in 25.8 %, and transesophageal echocardiography (TEE) in 73.1 % of cases. They underwent ECV (after mean 16 h, range 4-48), in 65.3 % and PCV in 6.7 % of patients (amiodarone in 47.7 %, flecainide in 27.3 %, propafenone in 2.3 %) as first CV procedure. No CV was performed in 27.9 %, mainly due to spontaneous CV or pathologic TEE. Primary success rates were 86.7 % for electrical CV and 54.5 % for pharmacological CV. More patients in the ECV group compared to the PCV group received oral anticoagulation at discharge (79.2 vs. 59.1 %, p < 0.001), and at 60 days (77.5 vs. 56.8 %, p < 0.001). Further, at 60 days the proportion of patients in sinus rhythm was not different between groups (ECV 76.8 % vs. PCV 77.3 %). CONCLUSIONS: In large academic centres in Germany, the preferred CV method is electrical, mainly due to its easy access and to its higher success rate for the initial restoration of sinus rhythm. Considering the limitations of the open-label, non-randomised study design, overall short-term success rates appeared higher after ECV compared to PCV during hospitalisation, but not after 60 days.
Authors: Robby Nieuwlaat; Alessandro Capucci; A John Camm; S Bertil Olsson; Dietrich Andresen; D Wyn Davies; Stuart Cobbe; Günter Breithardt; Jean-Yves Le Heuzey; Martin H Prins; Samuel Lévy; Harry J G M Crijns Journal: Eur Heart J Date: 2005-10-04 Impact factor: 29.983
Authors: Humberto Vidaillet; Juan F Granada; P o-Huang Chyou; Karen Maassen; Mario Ortiz; Juan N Pulido; Param Sharma; Peter N Smith; John Hayes Journal: Am J Med Date: 2002-10-01 Impact factor: 4.965
Authors: Jeroen M L Hendriks; Rianne de Wit; Harry J G M Crijns; Hubertus J M Vrijhoef; Martin H Prins; Ron Pisters; Laurent A F G Pison; Yuri Blaauw; Robert G Tieleman Journal: Eur Heart J Date: 2012-03-27 Impact factor: 29.983
Authors: S Mittal; S Ayati; K M Stein; D Schwartzman; D Cavlovich; P J Tchou; S M Markowitz; D J Slotwiner; M A Scheiner; B B Lerman Journal: Circulation Date: 2000-03-21 Impact factor: 29.690
Authors: Thomas J Wang; Martin G Larson; Daniel Levy; Ramachandran S Vasan; Eric P Leip; Philip A Wolf; Ralph B D'Agostino; Joanne M Murabito; William B Kannel; Emelia J Benjamin Journal: Circulation Date: 2003-05-27 Impact factor: 29.690
Authors: Thomas Meinertz; Wilhelm Kirch; Ludger Rosin; David Pittrow; Stefan N Willich; Paulus Kirchhof Journal: Clin Res Cardiol Date: 2011-05-01 Impact factor: 5.460
Authors: Reza Wakili; Sebastian Clauss; Viola Schmidt; Michael Ulbrich; Anton Hahnefeld; Franziska Schüssler; Johannes Siebermair; Stefan Kääb; Heidi L Estner Journal: Clin Res Cardiol Date: 2013-10-06 Impact factor: 5.460
Authors: Antonio Bonora; Gianni Turcato; Elena Franchi; Gabriele Taioli; Alice Dilda; Germana Zerman; Antonio Maccagnani; Claudio Pistorelli; Oliviero Olivieri Journal: Intern Emerg Med Date: 2016-07-06 Impact factor: 3.397
Authors: Marita Knudsen Pope; Dan Atar; Arne Svilaas; Torstein Hole; Jørn Dalsgaard Nielsen; Ulrik Hintze; Milita Crisby; Pekka Raatikainen; K E Juhani Airaksinen; Saverio Virdone; Karen Pieper; Gloria Kayani; Jean-Yves Le Heuzey; Jan Steffel; Janina Stepinska; Jean-Pierre Bassand; A John Camm Journal: Ann Med Date: 2021-12 Impact factor: 4.709
Authors: Eva A H Lanters; Denise M S van Marion; Charles Kik; Herman Steen; Ad J J C Bogers; Maurits A Allessie; Bianca J J M Brundel; Natasja M S de Groot Journal: J Transl Med Date: 2015-11-05 Impact factor: 5.531
Authors: Gregory Y H Lip; Sana M Al-Khatib; Francisco G Cosio; Amitava Banerjee; Irina Savelieva; Jeremy Ruskin; Dan Blendea; Stanley Nattel; Joseph De Bono; Jennifer M Conroy; Paul L Hess; Eduard Guasch; Jonathan L Halperin; Paulus Kirchhof; M Dolores G Cosio; A John Camm Journal: J Am Heart Assoc Date: 2014-08-27 Impact factor: 5.501
Authors: Maciej T Wybraniec; Wojciech Wróbel; Katarzyna Wilkosz; Karolina Wrona; Karolina Bula; Katarzyna Mizia-Stec Journal: J Am Heart Assoc Date: 2018-10-16 Impact factor: 5.501